More importantly, both studies demonstrated that transient androgen treatment resulted in induction of TMPRSS2: ERG fusion in prostate cancer cells, suggesting that androgen may play an important role in prostate cancer predisposition. This evidence concerns the gene TMPRSS2 and prostate carcinoma.